Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Kazuya Hosokawa , Abe Kotaro Added: 1 year ago
AHA 2023 — Dr Kazuya Hosokawa and Dr Abe Kotaro (Kyushu University Hospital, JP) join us to share the findings of the KABUKI trial (NCT04730037). The aim of KABUKI (Daiichi Sankyo) is to assess whether edoxaban, a direct factor Xa inhibitor, is noninferior to warfarin in preventing worsening of chronic thromboembolic pulmonary hypertension (CTEPH).This investigator-initiated, multicenter, phase 3… View more
Author(s): Harriette Van Spall , Luke Laffin Added: 3 months ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial… View more
Job title: Associate Professor
Job title: Assistant Professor of Medicine
Personal History Dr Vineet Agrawal is a physician-scientist and is Assistant Professor of Medicine at the Vanderbilt University Medical Center. He is from Omaha, Nebraska.1, 2, 5 Academic History In 2006, Dr Agrawal completed his undergraduate training at Duke University in Biomedical and Electrical Engineering. In 2012, he completed his MD and PhD in the Medical Scientist Training… View more
Research Area(s) / Expertise: Job title: Assistant Professor of Medicine and Director of the Pulmonary Hypertension Clinic